Literature DB >> 14554095

Cellular specificity of HIV-1 replication can be controlled by LTR sequences.

Edward Reed-Inderbitzin1, Wendy Maury.   

Abstract

Two well-established determinants of retroviral tropism are envelope sequences that regulate entry and LTR sequences that can regulate viral expression in a cell-specific manner. Studies with human immunodeficiency virus-1 (HIV-1) have demonstrated that tropism of this virus maps primarily to variable envelope sequences. Studies have demonstrated that T cell and macrophage-specific transcription factor binding motifs exist in the upstream region of the LTR U3; however, the ability of the core enhancer/promoter proximal elements (two NF-kappaB and three Sp1 sites) to function well in macrophages and T cells have led many to conclude that HIV LTR sequences are not primary determinants of HIV tropism. To determine if cellular specificity could be imparted to HIV by the core enhancer elements, the enhancer/promoter proximal region of the HIV LTR was substituted with motifs that control gene expression in a myeloid-specific manner. The enhancer region from equine infectious anemia virus (EIAV) when substituted for the HIV enhancer/promoter proximal region was found to drive expression in a macrophage-specific manner and was responsive to HIV Tat. The addition of a 5' methylation-dependent binding site (MDBP) and a promoter proximal Sp1 motif increased expression without altering cellular specificity. Spacing between the promoter proximal region and the TATA box was also found to influence LTR activity. Infectivity studies using chimeric LTRs within the context of a dual-tropic infectious molecular clone established that these LTRs directed HIV replication and production of infectious virions in macrophages but not primary T cells or T cell lines. This investigation demonstrates that cellular specificity can be imparted onto HIV-1 replication at the level of viral transcription and not entry.

Entities:  

Mesh:

Year:  2003        PMID: 14554095     DOI: 10.1016/s0042-6822(03)00508-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Transcriptional regulation of early transposon elements, an active family of mouse long terminal repeat retrotransposons.

Authors:  Irina A Maksakova; Dixie L Mager
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

4.  Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus.

Authors:  Melinda A Brindley; Wendy Maury
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Synthesis of chroman aldehydes that inhibit HIV.

Authors:  George A Kraus; John Mengwasser; Wendy Maury; ChoonSeok Oh
Journal:  Bioorg Med Chem Lett       Date:  2011-01-14       Impact factor: 2.823

Review 6.  HIV UTR, LTR, and Epigenetic Immunity.

Authors:  Jielin Zhang; Clyde Crumpacker
Journal:  Viruses       Date:  2022-05-18       Impact factor: 5.818

7.  Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.

Authors:  Melinda A Brindley; Laura Hughes; Autumn Ruiz; Paul B McCray; Anthony Sanchez; David A Sanders; Wendy Maury
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

8.  Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.

Authors:  Diane F Birt; Mark P Widrlechner; Kimberly Dp Hammer; Matthew L Hillwig; Jingqiang Wei; George A Kraus; Patricia A Murphy; Joeann McCoy; Eve S Wurtele; Jeffrey D Neighbors; David F Wiemer; Wendy J Maury; Jason P Price
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

9.  Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors.

Authors:  Kathrina Quinn; Melinda A Brindley; Melodie L Weller; Nikola Kaludov; Andrew Kondratowicz; Catherine L Hunt; Patrick L Sinn; Paul B McCray; Colleen S Stein; Beverly L Davidson; Ramon Flick; Robert Mandell; William Staplin; Wendy Maury; John A Chiorini
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

10.  Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L.

Authors:  ChoonSeok Oh; Jason Price; Melinda A Brindley; Mark P Widrlechner; Luping Qu; Joe-Ann McCoy; Patricia Murphy; Cathy Hauck; Wendy Maury
Journal:  Virol J       Date:  2011-04-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.